Immunotherapy of Superficial Bladder Cancer-Reference-Cited by-同舟云学术

Immunotherapy of Superficial Bladder Cancer

Published:1982-11 Issue:5 Volume:128 Page:891-894
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Shapiro Amos¹²,Kadmon Dov¹²,Catalona William J.¹²,Ratliff Timothy L.¹²

Affiliation:

1. From the Division of Urology, Washington University School of Medicine, St. Louis, Missouri

2. Hadassah University Hospital, Jerusalem, Israel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference21 articles.

1. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors;Morales;J. Urol.,1976

2. Immunotherapy of guinea pig cancer with BCG;Zbar;Cancer,1974

3. The effect of BCG on the dog bladder;Bloomberg;Invest. Urol.,1975

4. Treatment of superficial bladder cancer with intravesical BCG. Abstract C-160;Camacho;Proc. Amer. Ass. Cancer Res. and Amer. Soc. Clin. Oncol.,1980

5. BCG immunotherapy of bladder cancer: inhibition of tumor recurrence and associated immune responses;Lamm;Cancer,1981

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Checkpoint inhibition: new treatment options in urologic cancer;Acta Clinica Belgica;2017-01-02

2. Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Interferon-Induced Apoptosis in Human Bladder Cancer Cells;Cancer Research;2004-12-15

3. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N -butyl- N -(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response;Journal of Cancer Research and Clinical Oncology;2000-02-18

4. Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration;Journal of Cancer Research and Clinical Oncology;1998-03

5. Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression.;Journal of Clinical Oncology;1996-06